Clinical Trial

GDF-15 and Early Outcomes After LVAD Implantation

Study acronym: LVAD-GDF15
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated August 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.
Trial Details
NCT Number NCT07497308
Lead Sponsor Akdeniz University
Conditions Advanced Heart Failure, Left Ventricular Assist Device Implantation
Enrollment 48 participants
Start Date 2026-02-04
Primary Completion 2026-08-10 (estimated)
Study Completion 2026-12-23 (estimated)
Updated on ClinicalTrials.gov 2026-03-27